Previous Article | Next Article ![]()
Journal of Bacteriology, February 2005, p. 1266-1275, Vol. 187, No. 4
0021-9193/05/$08.00+0 doi:10.1128/JB.187.4.1266-1275.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Acetate Pathway Poisons Recombinational Repair-Deficient Mutants of Escherichia coli
John Stansbury, and
Andrei Kuzminov*
Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois
Received 19 June 2004/ Accepted 12 November 2004
|
|
|---|
acetyl coenzyme A interconversion. Using precise deletions of either ackA or pta, we showed that either mutation makes E. coli cells dependent on RecA or RecBCD enzymes at high temperature, suggesting dependence on recombinational repair rather than on the RecBCD-catalyzed linear DNA degradation. Complete inhibition of growth of pta/ackA rec mutants was observed only in the presence of nearby growing cells, indicating cross-inhibition. pta rec mutants were sensitive to products of the mixed-acid fermentation of pyruvate, yet none of these substances inhibited growth of the double mutants in low-millimolar concentrations. pta, but not ackA, mutants also depend on late recombinational repair functions RuvABC or RecG. pta/ackA recF mutants are viable, suggesting, together with the inviability of pta/ackA recBC mutants, that chromosomal lesions due to the pta/ackA defect are of the double-strand-break type. We have isolated three insertional suppressors that allow slow growth of pta recBC(Ts) cells under nonpermissive conditions; all three are in or near genes with unknown functions. Although they do not form colonies, ackA rec and pta rec mutants are not killed under the nonpermissive conditions, exemplifying a case of synthetic inhibition rather than synthetic lethality. |
|
|---|
Chromosomal lesions are local DNA lesions with genomic consequences, because they block chromosomal replication and/or segregation, thus inactivating not only individual genes, in which they happened to occur, but the whole genetic system of the organism (22). Mechanistically, chromosomal lesions comprise DNA lesions that affect both DNA strands of a duplex opposite each other, the so-called two-strand lesions, the best-known examples of which are double-strand DNA breaks and interstrand cross-links (23). To fix chromosomal lesions, all organisms employ recombinational repair (36, 39) as well as some other DNA repair pathways like translesion DNA synthesis (14) and nonhomologous end joining (41). In eubacteria, recombinational repair is the major way to mend chromosomal lesions (23).
In Escherichia coli, two separate pathways for the repair of chromosomal lesions exist (23) (Fig. 1). The central step in both pathways is homologous strand exchange between damaged and intact duplexes which is catalyzed by RecA (9). However, the RecA protein itself is incompetent to initiate repair because it cannot recognize chromosomal lesions in their original form. Repair of unfillable single-strand gaps is initiated by the RecFOR complex of activities (34, 43), whereas repair of double-strand breaks is initiated by the RecBCD enzyme (20). Both activities target RecA to the corresponding chromosomal lesions and license RecA to displace single-stranded DNA (ssDNA)-binding protein from ssDNA, which is always associated with chromosomal lesions. The RecA-promoted strand exchange generates a region of hybrid DNA (in which the original chromosomal lesion can be repaired) bracketed by Holliday junctions. Removal of the spent RecA filaments and resolution of Holliday junctions require either RuvABC resolvasome or RecG helicase, the two alternative clean-up teams of recombinational repair (23) (Fig. 1).
![]() View larger version (26K): [in a new window] |
FIG. 1. A scheme of recombinational repair in E. coli. RecFOR activities license RecA polymerization of daughter-strand gaps, whereas the RecBC enzyme does the same for double-strand breaks. After the RecA-catalyzed homologous strand exchange enables one-strand repair (excision repair) to fix the irregularities in the individual DNA strands, RuvABC or RecG activities remove the spent RecA filaments and Holliday junctions from the repair intermediate, freeing the participating chromosomes.
|
|
|
|---|
Bacterial strains.
Bacterial strains were E. coli K-12 derivatives (Table 1). pta and ackA deletion-replacement alleles were confirmed by PCR. recA(Ts), recBC(Ts),
recA,
recBCD,
recF, recG, and
ruvABC mutations were confirmed by their characteristic UV sensitivities. Gene replacements with either chloramphenicol or kanamycin resistance markers were constructed according to the method described by Datsenko and Wanner (10). The sequences of the primers used in the construction of the replacement alleles are shown in Table 2.
|
View this table: [in a new window] |
TABLE 1. Strains
|
|
View this table: [in a new window] |
TABLE 2. Sequences of primers used for ackA and pta gene replacement
|
Pulsed-field gel electrophoresis. Cultures of strains to be tested, which were grown at either 28 or at 45°C, were normalized to an optical density at 600 nm (OD600) of 0.3. Cells from 1.5 ml of the normalized cultures were sedimented by centrifugation and resuspended in 60 µl of TE buffer. After incubation at 37°C for 2 min, 5 µl of 10 mg of proteinase K/ml was added, followed by 65 µl of 1.2% molten agarose in 0.2% sarcosyl-10 mM Tris HCl (pH 8.0)-5 mM EDTA (kept at 70°C). After vortexing and mixing by pipetting, 110 µl of the cell suspension in agarose was pipetted into a plug mold and was allowed to solidify for 2 to 10 min. Each plug was then placed in a small glass tube containing 1 ml of 1% sarcosyl-50 mM Tris-HCl (pH 8.0)-25 mM EDTA and incubated for 1 h at 60°C. Plugs were inserted into 1% agarose gel on 0.5x Tris-borate-EDTA buffer and run in a Gene Navigator unit (Amersham-Pharmacia) with hexagonal electrodes (10°C, 180 V, ramp 3 to 165 s, 20 h).
Insertional mutagenesis.
For Tn5 mutagenesis, 109 cells of SK129 [AB1157 recBC(Ts)] carrying
cI-expressing plasmid pKB252 (2) were infected with 108 particles of Tn5-carrying
(MMS704 [
b221 rex::Tn5 cI857], from Frank Stahl's collection) in a total volume of 150 µl of TM buffer (10 mM Tris HCl [pH 8.0], 10 mM MgSO4), giving a multiplicity of infection of 0.1. After 15 min on ice, injection was effected at 37°C for 5 min, and the adsorption mixture was transferred to 1.5 ml of LB broth and shaken at 28°C for 30 min. The culture was plated onto kanamycin- and tetracycline-supplemented LB plates which were incubated at 28°C for 2 days, and the colonies were screened for the inability to grow at 42°C on LB plates by toothpicking. The kanamycin resistance determinant from the temperature-sensitive candidates was P1 transduced into the recBC(Ts) parent to confirm the associated temperature sensitivity, indicative of dependence on the RecBCD enzyme. The position of the insert was identified by sequencing out of the transposon (using primer 93seq [5'-GCCCAGTCGGCCGCACGATG]) after subcloning the transposon halves with the neighboring chromosomal sequences and selection for the associated kanamycin resistance.
For an alternative insertional mutagenesis, we used pRL27, a plasmid carrying a hyperactive Tn5 transposase gene adjacent to the insertional cassette comprising two inverted Tn5 termini bracketing the kan gene plus the R6K pir-dependent origin (25). The cells of the strain to be mutagenized were electroporated with 10 ng of pRL27 and plated for kanamycin resistance with an immediate selection for the desired phenotype. Once the clones of interest were identified, total DNA from 2 ml of cultures grown overnight were prepared as described previously (24), and 1/20 of it was digested with MluI, ligated onto itself, and electroporated into DH5
pir+ cells with selection for kanamycin resistance. The retrieved plasmids were digested with MluI, and the smallest plasmid was selected for sequencing. The two primers used for sequencing of pRL27 inserts were 27 ori (5'-AACAAGCCAGGGATGTAACG [the ori side of the insert]) and 27 kan (5'-CAGCAACACCTTCTTCACGA [the kan side of the insert]).
Enrichment for mutants inhibited in the absence of RecBC.
The enrichment for mutants inhibited in the absence of RecBC is based on the observation that recombination-dependent mutants, although unable to form colonies when recombinational repair is inactivated, maintain viability for several hours and resume growth once the recombinational repair capacity is restored. Transient growth inhibition due to recombinational repair deficiency allows recombination-dependent mutants to survive treatments with antibiotics, like ampicillin, that kill growing cells. To enrich for recBC-dependent mutants, recBC(Ts) cells were mutagenized (as described above) and plated onto LB agar supplemented with kanamycin to obtain
1,000 colonies per plate. The next day, 1 ml of LB broth per plate was used to wash off and combine
5,000 colonies. The cell suspension was diluted to 107 cells/ml into 40 ml of LB broth, and the culture was pregrown at 42°C for 1 h to inhibit rec-dependent cells. At this point, ampicillin was added to 100 µg/ml, and incubation at 42°C was continued for 4 more hours, at which point the culture cleared, indicating cell lysis. The surviving cells were collected by centrifugation (15,000 x g, 10 min) and resuspended in 1 ml of LB broth without ampicillin. Fifty microliters of various dilutions of this suspension was spread to single colonies on LB plates supplemented with kanamycin and incubated at 28°C. The next day, 100 colonies were toothpicked to check for the inability to grow at 42°C. One of the multiple temperature-sensitive clones thus obtained (that were assumed to be all siblings) was saved for further analysis.
Sandwich plating.
A 25-ml LB plate was overlaid with a 3.5-ml layer of top agar containing 300 µl of a mid-log-phase AB1157 culture (
1 x 108 cell/ml) and incubated at 37°C for 4 h. The plate was then overlaid with another 3.5 ml of top agar containing 175 µl of 100x stock of kanamycin (to eventually produce 25 µg of kanamycin/ml per entire
36-ml plate). After 2 min, a third 3.5-ml layer of top agar containing 500 µl of the pRL27-electroporated culture of the pta recBC(Ts) mutant was added. The plate was then incubated at 42°C for 36 to 48 h.
|
|
|---|
![]() View larger version (13K): [in a new window] |
FIG. 2. A scheme of acetate acetyl-CoA conversion and the genes involved. The elements of the ackA-pta operon are drawn to scale. The ackA gene is 1,202 bp, whereas the pta gene is 2,145 bp. The two promoters are shown as small arrows on long vertical stems. The positions of pRL27 and Tn5 inserts are indicated by filled triangles on vertical stems.
|
Chromosomal fragmentation in ackA+ and ackA mutant cells.
Deletion-replacement alleles
ackA::kan and
pta::kan with the corresponding open reading frames precisely removed as well as an
ackA allele with the drug resistance gene removed were constructed. Both
ackA (data not shown) and
pta (Fig. 3A) mutations made the original recBC(Ts) strain unable to grow at 42°C, confirming the observations made with Tn5 and pRL27 insertions.
![]() View larger version (49K): [in a new window] |
FIG. 3. pta/ ackA recBCD mutants are inviable and fragment their chromosome. A. pta recA(Ts) and pta recBC(Ts) are inviable at 42°C. Serial 10-fold dilutions of growing cultures were spotted onto plates which were incubated at the indicated temperatures for 36 to 48 h. The strains are as follows: for pta, JB17; for recA(Ts), JC9941; for pta recA(Ts), JS2; for recBC(Ts), SK129; for pta recBC(Ts), JS1. B. Pulsed-field gel of chromosomal DNA isolated from AB1157, recBC(Ts), ackA, and ackA recBC(Ts). The cells were grown at 45°C to an OD600 of 0.3. MWMYC, yeast chromosomes serving as molecular weight markers (their length in kilobase pairs is indicated on the left). The strains are as follows: for recBC(Ts), SK129; for ackA, IYS4; for ackA recBC(Ts), IYS6.
|
ackA and
pta mutants depend on RecA and RecBC.
In terms of DNA repair, dependence of an E. coli mutant on RecBCD enzyme indicates that the mutant relies on either linear DNA degradation or recombinational repair of DNA nicks or breaks. If the former is true, the mutant is viable in combination with recA inactivation (18, 40); if the latter is the case, the mutant requires RecA as well as RecBCD (5, 16, 19). To see whether ackA and pta mutants depend on DNA degradation capabilities or recombinational repair capabilities of RecBCD, we combined them with the recA(Ts) mutation and found that the resulting strains are inviable at 42°C (Fig. 3A and data not shown), suggesting the dependence of ackA-pta mutants on recombinational repair.
pta and ackA mutants are sensitive to cross-inhibition. Remarkably, when we spot tested ackA rec (data not shown) or pta rec (Fig. 4A) cells at 42°C or even at 45°C on individual LB plates rather than on a common plate with other strains, the double mutants were able to form small colonies, suggesting that the inability of the same strains to form colonies on the original plates was due to cross-inhibition from the growing neighbors (which can be seen on the lower-right plate shown in Fig. 4A). To eliminate possible inconsistencies due to this cross-inhibition by neighbors, from then on, we scored ackA rec and pta rec double-mutant phenotypes on plates with cross-inhibiting streaks of AB1157, which made the mutant phenotype unequivocal (Fig. 4B).
![]() View larger version (74K): [in a new window] |
FIG. 4. pta/ackA rec mutants are inviable at temperatures of 42°C and higher in the presence of growing cells. Serial 10-fold dilutions of growing cultures were spotted onto plates which were incubated at the indicated temperatures. Where present, cross-inhibiting spots or streaks were those of AB1157. A. pta recA(Ts) is viable at 42°C when spotted onto a plate without other strains present. Incubation at both temperatures was done for 36 h. Note cross-inhibition from the AB1157 spot (the bottom-right plate). The strain is JS2. B. A typical cross-inhibition plate. Incubation was done for 36 h at 28°C but for only 24 h at 45°C. The strains are as follows: for recA(Ts), JC9941; for pta, JS4; for pta recA(Ts), JS6; for ackA, IYS4; for ackA recA(Ts), IYS7.
|
![]() View larger version (67K): [in a new window] |
FIG. 5. pta recA(Ts) and pta recBC(Ts) cells cannot grow at 42°C on spent medium or on medium containing only yeast extract. Serial 10-fold dilutions of growing cultures were spotted onto plates which were incubated at the indicated temperatures for 36 to 48 h. Where present, cross-inhibiting spots or streaks were those of AB1157. A. pta mutants grow better on a mid-log medium but cannot grow on a spent medium. Stationary LB, a sterilized supernatant of a saturated AB1157 culture solidified with 1.5% agar; mid-log LB, a sterilized supernatant of a growing AB1157 culture (OD600 of 0.5) solidified with 1.5% agar. The strains are as follows: for pta, IYS3; for recBC(Ts), SK129; for pta recBC(Ts), IYS1; for recA(Ts), JC9941; for pta recA(Ts), IYS2. B. Yeast extract medium does not support growth of a pta recA(Ts) mutant at 42°C. The medium contains (per liter) 2.5 g of YE, 5 g of NaCl, and 15 g of agar (pH 7.2). The strain is JS6.
|
pta rec mutants are sensitive to products of mixed-acid fermentation of pyruvate. When grown aerobically in rich medium, E. coli turns pyruvate exclusively into acetyl-CoA and then uses the pta-ackA pathway to dump the excess acetate, which is excreted and then reused as the cells enter stationary phase (8, 12). To test the idea that cross-inhibition is due to pta rec double mutant sensitivity to acetate excreted by their pta+/ackA+ neighbors, we plated pta recA(Ts) and pta single-mutant strains at 42°C on LB plates supplemented with increasing concentrations of acetate. We found that the double mutant could not grow in the presence of acetate in excess of 50 to 60 mM, whereas the single mutants grew normally in the presence of 150 mM acetate (Table 3). Still, the inhibiting concentration of acetate was at least 10 times higher than the maximal concentration of acetate that accumulated in cultures of rapidly growing cells (8, 45). Moreover, the pta/ackA rec double-mutant strains were inhibited equally well by growing pta/ackA single-mutant neighbors (data not shown), ruling out acetate as the inhibitor.
|
View this table: [in a new window] |
TABLE 3. Concentrations of various metabolites that completely inhibit growth of pta recA(Ts) mutants at 42°C
|
![]() View larger version (16K): [in a new window] |
FIG. 6. Metabolic neighbors of the pta-ackA pathway during anaerobic growth in a rich medium. The aerobic overflow pathway (phosphoenolpyruvate pyruvate acetyl-CoA acetate) is indicated by boldface arrows. The anaerobic mixed-acid fermentation is shown by thin arrows with open arrowheads. Excreted products are marked by thick downward open arrows. Only the key substances are shown.
|
To quantify this inhibition, we spotted serial dilutions of saturated cultures, grew the spots under inhibitory conditions, and determined the titer of the CFU in the "2" dilution spot at the permissive conditions (Fig. 7A). The titers of single rec or ackA mutant spots determined by this procedure were similar to the titer of spots of wild-type cells (Fig. 7B). However, the titer of ackA rec mutant spots was down by 2 orders of magnitude. Thus, although ackA rec and pta rec mutant cells do not lose viability in the nonpermissive conditions, they in effect form 100-times-smaller colonies, which makes them almost invisible. We suggest that ackA rec and pta rec combinations be called synthetically inhibited rather than synthetically lethal.
![]() View larger version (37K): [in a new window] |
FIG. 7. Quantification of ackA recBC(Ts) and ackA recA(Ts) inhibition relative to wild-type or single mutant strains. A. A representative plate to show the spots that were taken out for the analysis (circled). The strains are as follows: for recBC(Ts), SK129; for ackA, IYS4; for ackA recBC(Ts), IYS6. B. The titers of CFU. The data are averages of two to five independent determinations ± standard errors.
|
acetate pathway is inactivated. We found that ackA and pta mutants do not require RecF, either with or without cross-inhibition (Fig. 8 and data not shown), suggesting that the chromosomal lesions in these mutants do not include daughter-strand gaps. On the other hand, we found that pta mutants depend on both RecG and RuvABC (with cross-inhibition at 42°C) (Fig. 8). This result is unexpected because the late phase of recombinational repair is believed to be catalyzed by either activity, so RecA-dependent mutants usually show dependence on both late activities but could survive if one of them is still active. In contrast to the
pta mutant, our
ackA mutant was viable in combination with either recG or ruvABC mutations (data not shown), which was the only difference in phenotypes between pta and ackA mutants detected in this work.
![]() View larger version (122K): [in a new window] |
FIG. 8. pta mutants are viable in combination with recF inactivation but cannot tolerate recG or ruvABC inactivation at 42°C. Serial 10-fold dilutions of growing cultures were spotted onto plates which were incubated at the indicated temperatures for 36 to 48 h. Where present, cross-inhibiting spots or streaks were those of AB1157. The strains are as follows: for recG, N4452; for pta recG, JS9; for recF, JC9239; for pta recF, JS8; for ruvABC, AM547; for pta ruvABC, JS7.
|
recA pta/ackA and
recBCD pta strains at low temperature, and we indeed recovered the double mutants. The mutants were fully viable at 28 or even 37°C but, as expected, were unable to form colonies at 42 or 45°C, especially with cross-inhibition (data not shown). We conclude that pta/ackA strains have problems with chromosomes only at high temperature, especially when there are growing cells nearby.
Suppressors of pta rec synthetic inhibition.
Although AB1157 is a standard wild-type strain for DNA metabolism studies of E. coli, it was derived through several mutagenesis rounds (1) and may therefore contain uncharacterized metabolic defects which modify behaviors of other mutations. Indeed, when we introduced
ackA or
pta mutants into the less-manipulated MG1655 strain (1), we observed only moderate inhibition in recA or recBCD mutant variants (data not shown), suggesting that the pta rec and ackA rec inhibition is specific for the AB1157 background. However, since we were interested in the mechanisms of Rec dependence, we could still study them in the AB1157 background, where the inhibition of ackA rec and pta rec double mutants is strong.
To gain insights into the mechanism of inviability of pta rec mutants, we employed pRL27 mutagenesis to isolate inactivational suppressors which allow pta rec mutants to grow under nonpermissive conditions. For this, we carried out the insertional mutagenesis in the pta recBC(Ts) mutants and plated the mutagenized cells with cross-inhibition at 42°C (see Materials and Methods). The chromosomal inserts from the colonies that grew under these nonpermissive conditions were P1 transduced into the parental pta recBC(Ts) strain and confirmed to suppress its synthetically lethal phenotype. This way, we isolated three weak suppressors, allowing slow growth of the resulting triple mutants (data not shown). We identified positions of inserts in these suppressors by sequencing (Fig. 9). One insert was found in the 583-bp intergenic region between the convergent yjhR and yjhS genes, the second insert was found to inactivate the yhhZ gene, and the third insert inactivated the yliF gene; all genes are currently annotated as "function unknown." The results of the suppressor analysis are considered in Discussion.
![]() View larger version (10K): [in a new window] |
FIG. 9. Position and orientation of pRL27 inserts relative to the chromosomal regions in the suppressor mutants. The vicinity maps of the disrupted gene with exact chromosomal coordinates were generated with the Colibri server (http://genolist.pasteur.fr/Colibri/genome.cgi). Open reading frames and their direction are shown by thin gray arrows identified by gene names. The positions of pRL27 inserts are shown by short arrows on sticks, with the orientation of these arrows indicating the orientation of the kan gene of the insert.
|
|
|
|---|
The dependence of a mutant on recombinational repair is generally interpreted as an increased level of chromosomal lesions caused by the mutation (5, 19), but the mechanisms leading to chromosomal lesions in pta and ackA mutants are currently obscure. One (less likely) possibility is that the opposite defects in production of acetyl phosphate (too much acetyl-phosphate in ackA mutants and too little acetyl-phosphate in pta mutants), which is a known signaling metabolite (27, 42, 44), cause chromosomal lesions via disregulated signaling. This explanation predicts that the synthetic inhibition of pta/ackA rec double mutants will be relieved by inactivation of the target mechanisms of acetyl phosphate signaling. One of the isolated suppressors of the pta recBC synthetic inhibition inactivates yliF, which codes for a GGDEF family protein of unknown function; the members of this family are widespread in eubacterial genomes and are often found in association with two-component response regulators. The enzymatic reaction catalyzed by these proteins is nucleotide cyclization (13).
Another explanation for the synthetic inhibition of pta rec and ackA rec mutants is that the inability of pta and ackA mutants to dump the excess of acetyl-CoA, which is a source of acetyl groups for numerous acetylation enzymes, causes chromosomal lesions via spurious acetylation of DNA-processing enzymes. This explanation predicts that suppressors of pta/ackA rec synthetic inhibition should inactivate acetyltransferases that catalyze this acetylation. Another insertional suppressor of the pta recBC inviability that we found in yhhZ is just downstream of yhhY, which is a putative acetyltransferase of the GNAT family. If the YhhY protein is somehow inactive in our yhhZ mutant, this would be consistent with the idea that the excess of acetyl-CoA causes spurious acetylation.
Yet another explanation for the synthetic inhibition of pta/ackA rec mutants is that the observed upregulation of the tricarboxylic acid cycle in pta/ackA mutants (44) leads to an increase in reactive oxygen species, elevating the background DNA modification. This explanation predicts that suppressors of pta/ackA rec synthetic inhibition may slow down the tricarboxylic acid cycle or inactivate DNA repair activities that remove modified DNA bases, thus interfering with DNA replication. The third suppressor insert landed in the intergenic region between yjhR and yjhS. yjhR, a gene likely to be affected by the insertion due to the antisense effect of the kanamycin resistance gene expression, codes for a putative DNA helicase of superfamily I, to which RecB and RecD helicases (components of the RecBCD enzyme) also belong (15). Thus, yjhR suppressor is compatible with the DNA modification or repair explanation. On the other hand, yjhS codes for a conserved hypothetical protein which is highly related (e-102) to a protein from a cryptic prophage, CP-933P of E. coli O157:H7 EDL933. Interestingly, among the distant homologs of YjhS is a probable acetyl xylan esterase, AxeA, with a possible function in polysaccharide degradation (2e-04) and, with a very low score (8.0), a putative N-acetyltransferase. In summary, the results of our suppressor analysis are intriguing and suggestive but at this point do not allow us to clearly distinguish among the three possible reasons (spurious acetylation of proteins, signaling defect, or DNA modification or repair) why ackA/pta rec double mutants are synthetically inhibited.
Delineating the phenomena of synthetic lethality and synthetic inhibition proved to be the main crux of this work. Conventional tools used in previous studies of recA synthetic lethals, like quantification of chromosomal fragmentation by pulsed-field gel electrophoresis and suppressor analysis (5, 19, 38), are harder to implement in the case of ackA and pta mutants. Finding better conditions will allow us to isolate more suppressors, while biochemical characterization of the proteins inactivated by suppressor mutations should provide insights into the mechanisms involved in conditional recombinational repair dependence of pta and ackA mutants.
pta::cam allele and to Paula Welander for isolation of the original ackA::pRL27 mutant. We thank Alvin John Clark, Ichizo Kobayashi, Richard Kolodner, Sydney Kushner, Robert G. Lloyd, William Metcalf, and Benedicte Michel for providing strains and plasmids and Elena Kouzminova for her help, encouragement, and discussion of results as well as for critical reading of the manuscript. This work was supported by grant MCB-0196020 from the National Science Foundation.
Present address: Department of Microbiology, Yale University School of Medicine, New Haven, CT 06536-0812. ![]()
|
|
|---|
. Proc. Natl. Acad. Sci. USA 73:4174-4178.
. Microbiol. Mol. Biol. Rev. 63:751-813.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»